Organogenesis Inc.

ORGO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.40

-$0.02 (-1.41%)

At close: Sep 21, 2026, 4:00 PM ET

$1.40

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-1.41%

(1D)

Rating

Updated: Aug 11, 2026

Fundamentals Weak

Market Sentiment Bearish

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $180.14M

1D Range

1.38 1.41

52W Range

1.34 7.08

Valuation (TTM)

PE -1.69

PB 0.63

EV/EBITDA -42.51

Valuation (NTM)

Forward PE 8.55

Forward PEG 0.02

Price Target $2.50

Cash Flow

FCF Yield 11.6%

SBC Adj. FCF Yield 3.8%

SBC Impact -67.5%

Margins

Gross Margin 67.6%

Operating Margin -6.4%

FCF Margin 4.6%

Growth (CAGR)

Revenue 3Y | 5Y -0.1% | 1.1%

Dil EPS 3Y | 5Y -96.3% | -310.6%

FCF 3Y | 5Y 108.6% | -5.5%

Returns

ROA -22.2%

ROE -24.2%

ROIC -8.1%

Financial Health

Net Cash

$46.1M

Current Ratio 3.52

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Organogenesis Holdings Inc. is a U.S.-based regenerative medicine firm that specializes in creating, producing, and marketing innovative therapies for advanced wound management, as well as surgical an...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 854

IPO Date Jan 4, 2017

Website organogenesis.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 5, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$2.50

Upside

+78.57%

Buy (1)

Hold (1)

Sell (0)

Analyst Details ➞